Hedge Fund Drops Million in Crinetics: Is It a Buy?
A major hedge fund just disclosed a multi-million stake in Crinetics, a rare-disease biotech. This article unpacks wh...
Find ways to stay ahead in budgeting with routine reviews, alerts, and smart adjustments that protect your financial path.
21,896 articlesA major hedge fund just disclosed a multi-million stake in Crinetics, a rare-disease biotech. This article unpacks wh...
Target rolls out a broad turnaround, including redesigned carts and a baby concierge service, but investors question ...
Kevin Warsh is sworn in as Fed chair with a crypto-forward stance, a development traders say could redefine policy an...
Prediction markets show the CLARITY Act odds collapsing from 75% to 50% in a single week, underscoring growing doubt ...
Broadcom is edging toward a 52-week peak as AI demand fuels revenue growth and capital returns. Analysts weigh buy, h...
Five weeks after Vanguard split three ETFs, VGT led the gauges, turning a post-split move into a meaningful performan...
Bitcoin has pulled back from its peak, but history offers clues about what may come next. This practical guide breaks...
This in-depth analysis examines signet (sig) 2027 earnings, focusing on Q1 2027 results, strategic levers, and what i...
Ciena’s stock tumbling taking center stage as its latest earnings signals weigh on the broader optical-networking spa...
SpaceX aims for the largest IPO in history, targeting a $135-per-share price and up to $75 billion in proceeds. Durin...
Is Byrna Technologies the next big opportunity in non-lethal protection? This analysis breaks down the growth case, k...
Oracle beat on earnings and grew its contract backlog to a record level, yet investors pounced on higher AI costs, se...